Mr. Glenn A. Eisenberg is a Co-Managing Director at Covance Preclinical Services GmbH, an Independent Director at US Ecology, Inc., a Chief Financial Officer at Sequenom, Inc., a Chief Financial Officer & Executive Vice President at Laboratory Corp. of America Holdings, a Vice President at LipoScience, Inc. and a Vice President at Dianon Systems, Inc. He is on the Board of Directors at US Ecology, Inc., Chiltern International Group Ltd., Covance, Inc., Chiltern International Holdings Ltd., Chiltern International Ltd., Clearstone Holdings (International) Ltd., Correlagen Diagnostics, Inc., Covance Clinical & Periapproval Services Ltd., Covance Clinical Research Unit Ltd., Covance Laboratories Ltd., Covance Ltd., Federation of Jewish Community Services of Montreal, LabCorp Neon Ltd., LabCorp UK Holdings Ltd., MAPI, Inc., Ockham Europe Ltd., Sciformix Corp., The Aultman Health Foundation and The Aultman Hospital. Mr. Eisenberg was previously employed as an Independent Director by Perspecta, Inc., an Independent Director by US Ecology, Inc. /Old/, a Lead Independent Director by Alpha Natural Resources, Inc., an Independent Director by Family Dollar Stores, Inc., an Executive Vice President-Finance & Administration by The Timken Co., a President & Chief Operating Officer by United Dominion Industries Ltd., a President by Citizens & Southern Corp. (Georgia), a Chief Financial Officer & Executive Vice President by SPX Corp., and a President by Timken U.S. Holdings LLC. He also served on the board at Alpha Natural Resources, Inc. /Old/. He received his undergraduate degree from Tulane University (Louisiana) and an MBA from Georgia State University.